A. Sholl
发表
H. Grimes,
David A Hildeman,
S. Kurtulus,
2011,
The Journal of Immunology.
H. Grimes,
David A Hildeman,
S. Kurtulus,
2011
.
F. Finkelman,
H. Grimes,
David A Hildeman,
2010
.
F. Finkelman,
H. Grimes,
David A Hildeman,
2010,
The Journal of Immunology.
F. Finkelman,
H. Grimes,
David A Hildeman,
2010
.
P. Fink,
D. Plas,
C. Chougnet,
2010
.
P. Fink,
D. Plas,
C. Chougnet,
2010
.
P. Fink,
D. Plas,
C. Chougnet,
2010
.
F. Finkelman,
David A Hildeman,
P. Tripathi,
2016,
European journal of immunology.
VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells.
L. Boon,
David A Hildeman,
A. Sholl,
2013,
Molecular therapy : the journal of the American Society of Gene Therapy.
T. Doetschman,
David A Hildeman,
A. Sholl,
2011,
Clinical immunology.
David A Hildeman,
P. Tripathi,
A. Sholl,
2009
.
David A Hildeman,
A. Sholl,
J. Bleesing,
2015,
The Journal of allergy and clinical immunology.
David A Hildeman,
P. Tripathi,
A. Sholl,
2009,
Journal of Virology.
Maha Almanan,
C. Chougnet,
David A Hildeman,
2017,
PLoS pathogens.
David A Hildeman,
S. Kurtulus,
A. Sholl,
2019,
Cell Death & Differentiation.
P. Bouillet,
D. Plas,
C. Chougnet,
2013,
Front. Immunol..
David A Hildeman,
S. Kurtulus,
P. Tripathi,
2014,
Cell Death and Differentiation.
F. Finkelman,
H. Grimes,
David A Hildeman,
2010
.
F. Finkelman,
David A Hildeman,
P. Tripathi,
2016,
European journal of immunology.
P. Fink,
D. Plas,
C. Chougnet,
2010
.